Neurologist, Kaiser Permanente
Neurology
Dr. Stephen T. Gancher, MD
|
|
Give Review
Stephen Gancher practices Neurology. He went to medical school at Wake Forest School of Medicine. He has 2 awards "Meaningful Use Stage 1 Certification" and "Top MD". Dr. Stephen T. Gancher is a published doctor. He published 27 publications, including: 'Controlled release levodopa/carbidopa 25/100 (Sinemet CR 25/100): pharmacokinetics and clinical efficacy in untreated parkinsonian patients.'
Publications
- Movement disorders in Multiple sclerosis.
- Pharmacodynamics of the hypotensive effect of levodopa in parkinsonian patients.
- Controlled release levodopa/carbidopa 25/100 (Sinemet CR 25/100): pharmacokinetics and clinical efficacy in untreated parkinsonian patients.
- Does an inhibitory action of levodopa contribute to motor fluctuations?
- Response to brief levodopa infusions in parkinsonian patients with and without motor fluctuations.
- Differences in the motor response to apomorphine between untreated and fluctuating patients with Parkinson's Disease.
- Effect of long-term therapy on the pharmacodynamics of levodopa. Relation to on-off phenomenon.
- Peripheral pharmacokinetics of apomorphine in humans.
- Motor fluctuations in Parkinson's Disease.
- The short-duration response to apomorphine: implications for the mechanism of dopaminergic effects in parkinsonism.
- Parkinson's Disease dyskinesias.
- Effect of peripheral catechol-O-methyltransferase inhibition on the pharmacokinetics and pharmacodynamics of levodopa in parkinsonian patients.
- Identification of two new KCNA1 mutations in episodic Ataxia/myokymia families.
- Episodic Ataxia/myokymia syndrome is associated with point mutations in the human potassium channel gene, KCNA1.
- A locus for the nystagmus-associated form of episodic Ataxia maps to an 11-cM region on chromosome 19p.
- 3-O-methyldopa and the response to levodopa in Parkinson's Disease.
- Diurnal responsiveness to apomorphine.
- Peripheral pharmacokinetics of levodopa in untreated, stable, and fluctuating parkinsonian patients.
- Autosomal dominant episodic Ataxia: a heterogeneous syndrome.
- Does tolerance develop to levodopa? Comparison of 2- and 21-H levodopa infusions.
- Absorption of apomorphine by various routes in parkinsonism.
- A 10-year follow-up--genotypic analysis disproves phenotypic classification.
- Apomorphine tolerance in Parkinson's Disease: lack of a dose effect.
- Time course of tolerance to apomorphine in parkinsonism.
- Apomorphine infusional therapy in Parkinson's Disease: clinical utility and lack of tolerance.
- Tolerance to apomorphine develops and reverses rapidly.
Schools
Wake Forest University School Of Medicine Medical Center Boulevard
Va Med Center
Oregon Health and Science University
Procedures Preformed
- EEG (Electroencephalogram)
- Non-Cosmetic Chemodenervation
Conditions Treated
- Alzheimer's Disease
- Ataxia
- Cerebral Artery Thrombosis
- Cerebrovascular Disease
- View All
Doctors Specialties
- Neurology
Accepted Insurances
Awards
- Meaningful Use Stage 1 Certification
- Top MD
Education
-
Oregon Health & Science University -
Wake Forest School of Medicine
Hospital
-
Providence Portland Medical Center
Helpful Reviews
Similar Doctors
|
Dr. Michael A. Leone, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jeff A. Kraakevik, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mark S. Yerby, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
Dr. Howard S. Taylor, MD |
|
|
Dr. Amit Kansara, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Vitalie Lupu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Elise D. Anderson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Scott D. Fromherz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Evelyn A. Curioso, MD |
|
|
Dr. Camilla E. Elven, MD |
|
|
Dr. Brian D. Denekas, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joshua L. Johnson III, MD |
|
|
David V. McHenry, PT
This Doctor is OpenDoctor Recommended.
|